Código QR (código de barras bidimensional)

A case report: Response to Osimertinib in non-small cell lung cancer patient with uncommon EGFR mutation

Background: The epidermal growth factor receptor (EGFR) gene harbors a variety of pathogenic variants in non-small cell lung cancer (NSCLC) with several mutations within exons 18–21 serving as common targets for tyrosine kinase inhibitor (TKI) therapy. Osimertinib is a third generation TKI that was...

Fuld beskrivelse

Na minha lista:
Principais autores: Daniel J. Craig, Navkirat K. Kahlon, Danae M. Hamouda
Format: Artigo
Sprog:Inglês
Udgivet: Elsevier 2022-12-01
Serier:Current Problems in Cancer: Case Reports
Fag:
EGFR
Tyrosine kinase inhibitors
Osimertinib
Non-small cell lung cancer
Online adgang:http://www.sciencedirect.com/science/article/pii/S2666621922000527
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker